Mode
Text Size
Log in / Sign up

Oncology

1582 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Idiopathic premature adrenarche is associated with higher body mass index and insulin resistance markers
Oncology Meta-analysis
Idiopathic premature adrenarche is associated with higher body mass index and insulin resistance markers Premature Adrenarche Linked to Higher Risk of Insulin Resistance
This meta-analysis examined the relationship between idiopathic premature adrenarche and metabolic markers in females post-menarche. The fin…
Women with a history of premature adrenarche may show higher levels of insulin resistance and other markers related to metabolic health.
Autoimmune gastritis and pernicious anemia are associated with increased risks of gastric neoplasms
Oncology Meta-analysis
Autoimmune gastritis and pernicious anemia are associated with increased risks of gastric neoplasms Autoimmune gastritis and pernicious anemia linked to higher cancer risk
This meta-analysis evaluates the risk of gastric neoplasms in patients with autoimmune gastritis (AIG) and pernicious anemia (PA). The analy…
People with autoimmune gastritis or pernicious anemia face higher risks of certain stomach tumors and precancerous changes.
Exosomal miRNAs Show High Diagnostic Accuracy for Hepatocellular Carcinoma
Oncology Meta-analysis
Exosomal miRNAs Show High Diagnostic Accuracy for Hepatocellular Carcinoma Exosomal microRNAs show promise for detecting liver cancer
This meta-analysis evaluated exosomal microRNAs as non-invasive biomarkers for hepatocellular carcinoma across 1442 HCC patients, 761 health…
New data shows that specific tiny molecules in the blood could help doctors identify liver cancer more accurately in patients with liver dis…
Trastuzumab Deruxtecan Management of HER2 Positive Metastatic Breast Cancer with Visceral Crisis
Oncology Sys. Review
Trastuzumab Deruxtecan Management of HER2 Positive Metastatic Breast Cancer with Visceral Crisis Newer drug shows promise for advanced breast cancer and liver issues
A case report highlights the efficacy of trastuzumab deruxtecan in managing visceral crisis in HER2-positive metastatic breast cancer.
A new treatment approach may help patients with advanced breast cancer who are facing a sudden, serious crisis in their liver function.
PIWIL4 exhibits context-dependent roles in cancer progression and metabolic reprogramming across various cancer types
Oncology Sys. Review
PIWIL4 exhibits context-dependent roles in cancer progression and metabolic reprogramming across various cancer types Understanding the Role of PIWIL4 Protein in Different Types of Cancer
This systematic review synthesizes the role of PIWIL4 in cancer, highlighting its regulation of cell cycle control, apoptosis, and metabolic…
Scientists are studying how the PIWIL4 protein affects cancer growth and cell behavior to find better ways to treat patients.
Lenvatinib plus pembrolizumab yields 28-month survival in BRAF wild-type anaplastic thyroid cancer
Oncology Guideline
Lenvatinib plus pembrolizumab yields 28-month survival in BRAF wild-type anaplastic thyroid cancer Man With Rare Thyroid Cancer Alive at 28 Months
This single case report describes a 45-year-old man with metastatic anaplastic thyroid carcinoma treated with lenvatinib plus pembrolizumab …
A 45-year-old man with anaplastic thyroid cancer saw his disease stay controlled for 28 months on two drugs.
MDT-guided perioperative strategy and staged anticoagulation manage pancreatic cancer in a patient with Moyamoya disease
Oncology Guideline
MDT-guided perioperative strategy and staged anticoagulation manage pancreatic cancer in a patient with Moyamoya disease Multidisciplinary Strategy Helps Manage Moyamoya Disease and Pancreatic Cancer
This case report describes a multidisciplinary team-guided perioperative strategy for a patient with Moyamoya disease and pancreatic ductal …
A specialized surgical strategy helped a patient with both Moyamoya disease and pancreatic cancer undergo surgery without any neurological c…
Self-administered ivermectin and fenbendazole in a patient with metastatic melanoma showed mixed radiographic and ctDNA responses
Oncology Guideline
Self-administered ivermectin and fenbendazole in a patient with metastatic melanoma showed mixed radiographic and ctDNA responses One man with melanoma tries antiparasitic drugs for his cancer
This case report describes a 74-year-old man with metastatic melanoma who self-administered ivermectin and fenbendazole. The patient experie…
A man with advanced melanoma saw a temporary drop in cancer markers after taking ivermectin and fenbendazole, but the results were mixed.
Nodal staging in upper eyelid Merkel cell carcinoma may influence disease-free status and survival outcomes
Oncology Guideline
Nodal staging in upper eyelid Merkel cell carcinoma may influence disease-free status and survival outcomes Eyelid cancer cases show importance of staging for survival
This case report describes 3 patients with upper eyelid Merkel cell carcinoma undergoing wide local excision and reconstruction. One patient…
A small study of eyelid cancer shows that skipping certain staging steps can lead to rapid spread and death.
Gut-lung axis in lung cancer: soluble metabolites lead, neural pathways remain hypothetical
Oncology Sys. Review
Gut-lung axis in lung cancer: soluble metabolites lead, neural pathways remain hypothetical Gut Health Links May Influence Lung Cancer Treatment Paths
This narrative review with a systematic search examined 168 studies on the gut-lung axis in non-small-cell and small-cell lung cancer. Solub…
New research explores how the gut-lung axis and specific metabolites might play a role in managing lung cancer treatments.
Hamburg Life After Cancer Program protocol aims to improve quality of life in cancer survivors
Oncology RCT
Hamburg Life After Cancer Program protocol aims to improve quality of life in cancer survivors New Program Aims to Improve Quality of Life for Cancer Survivors
This study protocol describes a single-arm intervention for 500 cancer survivors aged 18 to 65 years. The program includes patient navigatio…
A new multi-layered support program is being designed to help cancer survivors improve their quality of life through personalized care and p…
Lipid metabolism reprogramming emerges as key mechanism of endocrine resistance in ER+ breast cancer
Oncology Sys. Review
Lipid metabolism reprogramming emerges as key mechanism of endocrine resistance in ER+ breast cancer Fat metabolism changes help breast cancer cells resist treatment
This systematic review synthesizes evidence that lipid metabolism reprogramming, including fatty acid synthesis, cholesterol metabolism, lip…
New research identifies how changes in fat metabolism allow certain breast cancer cells to survive and resist standard hormone therapies.